These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 12438536)
41. Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone. Kivistö KT; Lamberg TS; Neuvonen PJ Pharmacol Toxicol; 1999 Feb; 84(2):94-7. PubMed ID: 10068153 [TBL] [Abstract][Full Text] [Related]
42. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites. Sato H; Skelin I; Debonnel G; Diksic M Brain Res Bull; 2008 Mar; 75(5):545-55. PubMed ID: 18355630 [TBL] [Abstract][Full Text] [Related]
43. Comparison of the anticonflict effect of buspirone and its major metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in rats. Amano M; Goto A; Sakai A; Achiha M; nee Hara ; Takahashi N; Hara C; Ogawa N Jpn J Pharmacol; 1993 Apr; 61(4):311-7. PubMed ID: 8100593 [TBL] [Abstract][Full Text] [Related]
44. Clinical pharmacokinetics of oral buspirone in patients with impaired renal function. Caccia S; Vigano GL; Mingardi G; Garattini S; Gammans RE; Placchi M; Mayol RF; Pfeffer M Clin Pharmacokinet; 1988 Mar; 14(3):171-7. PubMed ID: 3370902 [TBL] [Abstract][Full Text] [Related]
45. Ambient temperature influences core body temperature response in rat lines bred for differences in sensitivity to 8-hydroxy-dipropylaminotetralin. Nicholas AC; Seiden LS J Pharmacol Exp Ther; 2003 Apr; 305(1):368-74. PubMed ID: 12649391 [TBL] [Abstract][Full Text] [Related]
46. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone. Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317 [TBL] [Abstract][Full Text] [Related]
47. The influences of aconitine, an active/toxic alkaloid from aconitum, on the oral pharmacokinetics of CYP3A probe drug buspirone in rats. Zhu L; Lu L; Guo E; Wu J; Wang Y; Hu M; Liu Z Drug Metab Lett; 2014; 8(2):135-44. PubMed ID: 25434398 [TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetic-pharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT1A receptor agonist flesinoxan. Zuideveld KP; van Gestel A; Peletier LA; Van der Graaf PH; Danhof M Eur J Pharmacol; 2002 Jun; 445(1-2):43-54. PubMed ID: 12065193 [TBL] [Abstract][Full Text] [Related]
49. Attenuation of somatodendritic responses to 8-hydroxy-2-di-npropylamino tetralin following long-term dietary sugar consumption in rats. Inam QU; Haleem MA; Haleem DJ J Coll Physicians Surg Pak; 2009 Jul; 19(7):401-5. PubMed ID: 19576144 [TBL] [Abstract][Full Text] [Related]
50. Simultaneous quantitation of buspirone and 1-(2-pyrimidinyl)piperazine in human plasma and urine by capillary gas chromatography-mass spectrometry. Sciacca MA; Duncan GF; Shea JP; Faulkner HC; Farmen RH; Pittman KA J Chromatogr; 1988 Jul; 428(2):265-74. PubMed ID: 3215930 [TBL] [Abstract][Full Text] [Related]
51. Different effects of intracerebral and systemic administration of buspirone in the forced swimming test: involvement of a metabolite. Cervo L; Grignaschi G; Samanin R Life Sci; 1988; 43(25):2095-102. PubMed ID: 2905409 [TBL] [Abstract][Full Text] [Related]
52. Effect of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine on hippocampal serotoninergic system, studied in freely moving rats. Grazia De Simoni M; Imeri L; De Luigi A; Fodritto F; Garattini S Life Sci; 1990; 46(3):197-205. PubMed ID: 1689445 [TBL] [Abstract][Full Text] [Related]
53. [The pharmacology of 1-(2-pyrimidinyl)piperazine, a metabolite of buspirone]. Komissarov IV; Dulenko VI; Kharin NA; Tolkunov SV; Talalaenko AN Farmakol Toksikol; 1989; 52(2):27-30. PubMed ID: 2568272 [TBL] [Abstract][Full Text] [Related]
54. [Electroencephalographic study with buspirone, a novel nonbenzodiazepine anxiolytic, and its major metabolite, 1-(2-pyrimidinyl)piperazine (1-PP), in rabbits]. Kawasaki H; Nakamura S; Takasaki K Nihon Yakurigaku Zasshi; 1990 Mar; 95(3):91-104. PubMed ID: 1972369 [TBL] [Abstract][Full Text] [Related]
55. Buspirone decreases physiological reactivity to unconditioned and conditioned aversive stimuli. Bond AJ; Wingrove J; Baylis M; Dalton J Psychopharmacology (Berl); 2003 Jan; 165(3):291-5. PubMed ID: 12420156 [TBL] [Abstract][Full Text] [Related]
56. Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study. Watanabe A; Hasegawa S; Nishi K; Nguyen KQ; Diksic M Brain Res Bull; 2006 Mar; 69(2):101-8. PubMed ID: 16533657 [TBL] [Abstract][Full Text] [Related]
58. Decrease of ethanol intake following repeated injection of serotonin-1A agonist in rats: relationship with receptor responsiveness. Hasnat A; Haider S; Perveen T; Kidwai IM; Haleem DJ J Coll Physicians Surg Pak; 2003 Jun; 13(6):305-8. PubMed ID: 12814524 [TBL] [Abstract][Full Text] [Related]
59. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo. Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781 [TBL] [Abstract][Full Text] [Related]
60. 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors. Rusyniak DE; Zaretskaia MV; Zaretsky DV; DiMicco JA J Pharmacol Exp Ther; 2007 Nov; 323(2):477-87. PubMed ID: 17702902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]